Relmada Therapeutics, Inc. (RLMD)
5.91
-0.24
(-3.90%)
USD |
NASDAQ |
Mar 13, 16:00
5.90
-0.01
(-0.17%)
After-Hours: 20:00
Relmada Therapeutics Total Liabilities (Quarterly) : 5.411M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 675.63M |
| Invivyd, Inc. | 35.34M |
| Arcellx, Inc. | 201.64M |
| AN2 Therapeutics, Inc. | 6.858M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.88M |
| Shareholders Equity (Quarterly) | 9.466M |
| Current Ratio | 2.862 |